She may be protesting too much… Vicki Gunvalson has been at the center of one of the largest scandals in reality TV history ever since her ex-BF Brooks Ayers decided to fake cancer on national television. And while the former Real Housewives star may have come clean about his fake documents, the OG of the OC is [...]
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association of scholars. read more
The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT).
November is Pancreatic Cancer Awareness Month, and Mayo Clinic Cancer Center experts are available to discuss this often fatal illness, risk factors, treatments and advances in research. Pancreatic cancer accounts for only 3 percent of all cancers but is the fourth leading cause of cancer death in the United States. According to the National Cancer Institute, by the […]
WASHINGTON (Nov. 18, 2015) - The Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center hosts "Fighting a Smarter War Against Cancer," a symposium for medical professionals, patients and advocates, Dec. 3-5, 2015 at Georgetown University.
University of Colorado Cancer Center study shows that some uninsured and low-income breast cancer patients do without even low-cost, high-benefit drugs.
A University of Colorado Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage. Show More Summary
Rather than targeting one or two specific genes or proteins that contribute to cancer, the task force was charged with researching a broad-spectrum approach. "This type of approach involves combinations of multiple low-toxicity agents that can collectively impact many pathways that are known to be important for the genesis and spread of cancer," said Kumar.
More bad news for meat eaters. A new study from the University of Texas’s MD Anderson Cancer Center has linked grilled and barbecued meat to kidney cancer. Unlike the recent Read More The post Study: Grilled Meat Linked to Kidney Cancer appeared first on Ecorazzi.
SEATTLE -- Advanced prostate cancer is a disease notoriously resistant to treatment. New research by scientists at Fred Hutchinson Cancer Research Center and the University of California, San Francisco sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer. Show More Summary
Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer. This small RNA fragment hit multiple targets, reducing androgen receptor signaling and reviving the potency of enzalutamide, a treatment for advanced prostate cancer. Show More Summary
Andy Sabin, of East Hampton, N.Y., has committed $30 million -- the philanthropist's largest grant to date -- to support research at The University of Texas MD Anderson Cancer Center.
Andy Cohen opens the Brooks Tells All interview with this disclaimer: “A few weeks ago, I sat down with Brooks Ayers for a one-on-one conversation. Since then, the City of Hope Medical Center revealed that Brooks was never treated for cancer at their facility, contrary to his claims. Show More Summary
Trial trains patients' re-engineered cells to chase down the cancer and destroy it
SAN ANTONIO (Nov. 12, 2015) - How does a protein called connexin put the clamps on cancer? Researchers in the School of Medicine at The University of Texas Health Science Center at San Antonio today reported an explanation. Study senior author Jean X. Show More Summary
TAMPA, Fla. (Nov. 12, 2015) - New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma. The results from the multicenter phase 2 study were published in the Nov. 5 issue of The New England Journal of Medicine. read more
TAMPA, Fla. - New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma. The results from the multicenter phase 2 study were published in the Nov. 5 issue of The New England Journal of Medicine.
Brooks Ayers, the ex-boyfriend of Vicki Gunvalson who became the center of controversy on season 10 of The Real Housewives of Orange County for his cancer diagnosis, still insists he has cancer despite the entire cast believing otherwise. However, he did come clean about fabricating medical documents to prove that he had undergone chemotherapy.
Alrighty, so Brooks Ayers sits on a throne of lies. In an attempt to convince viewers that he is battling cancer, Ayers presented E! News with medical records from City of Hope. Unfortunately, the renowned medical center confirmed with E! that they never treated Ayers for anything cancer-related. Show More Summary
There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive...Show More Summary